Antitumor Effects of Bortezomib (PS-341) on Primary Effusion Lymphomas

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403460
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search